Catalyst Wire Dossier Catalyst Wire Dossier

Livoletide

AZP-531 · Millendo Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Livoletide, covering 2021-02-17 to 2021-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome [Phase 2, Phase 3]

See pricing